Fig 1.
Typical phase contrast images of the MCTS growth for the three CRC lines taken at 0h, 24h and 48h in the absence of drug.
(A-C) HT29, (D-F) HCT116 and (G-I) SW480. Scale bars: 200 μm.
Fig 2.
Typical images of the follow-up of a SW480 MCTS.
Images taken at 0h, 24h, 32h and 48h in the absence of drug (A-F) or in presence of 10 μM of 5-FU dispensed at initial time 0h (G-L). The dotted line representing the initial spheroid size in A, G is reported on other images as a guide for the eye. Curved arrows indicate the spheroids transfer into a new well. Straight short arrows show the diffuse cell outer layer. Scale bar: 200 μm.
Fig 3.
Nature of cells in the outer layerof the SW480 spheroids at 48h.
(A-D) Phase contrast and (E-H) corresponding fluorescent images of living cells in green (calcein +) and dead cells in red (PI+) treated with 0, 2, 10 and 100 μM of 5-FU. Compared to control (A,E), a gradual disaggregation of peripheral cells appears clearly since 2 μM of 5-FU (B,F) to 100 μM (D,H). Cells in the outer layer are equally dead and living cells. Scale bar: 200 μm.
Fig 4.
An outer loose layer of cells breaks away from the MCTS under 10 μM of 5-FU treatment.
Typical images of MCTS of the three different CRC cell lines, HT29 (A-C), HCT116 (D-F) and SW480 (G-I) at three different times after drug administration ([5-FU] = 10μM): 24h (A, D, G), 32h (B, E, H) and 48h (C, F, I). In the absence of transfer, numerous dead cells appear on the diffuse outer cell layer for the HCT116 and SW480 MCTS. Scale bar: 200 μm.
Fig 5.
Number of dead cells within the cohesive core of MCTS under drug treatment after transfer to new wells.
(A) Typical fluorescence images at 48h of living cells in green (calcein +) and dead cells in red (PI+) in control SW480 MCTS or in presence of 5-FU (300 μM). (B) Quantification of PI+ dead cells per unit volume for each cell line as a function of the 5-FU concentration. Error bar = SEM (standard error of the mean), (n = 12 for each cell line). Scale bar: 200 μm.
Fig 6.
Volume of the cohesive core of MCTS under drug treatment after transfer to new wells.
Left. Typical images of spheroid cores at 48h for the three CRC cell lines after administration of 0 μM (A, E, I), 10 μM (B, F, J) or 100 μM (C, G, K) 5-FU. The dotted circle represents the size of the control MCTS which is reported as a guide for the eye on other panels. Right. Time series of the mean MCTS volume relative to initial volume at day 0 for each particular condition after 5-FU treatment ranging from 0 to 100 μM (only 3 drug concentrations are reported for clarity). (A-D) HT29, (E-H) HCT116 and (I-L) SW480. Error bars: SEM (n = 7–12 for each cell line). Scale bar: 200 μm.
Fig 7.
3D versus 2D 5-FU effect at 48h.
(A) 3D cell survival of HCT116, SW480 and HT29 MCTS 48 hours after 5-FU treatment ranging from 0 to 100 μM. Survival represents the ratio of MCTS volume at 48h for a given drug condition to the volume of control MCTS (n = 7–12). (B) 2D cell survival of HCT116, SW480 and HT29 cell lines 48 hours after 5-FU treatment ranging from 0 to 100 μM. Survival represents the ratio of the normalized cell area at 48h for a given drug condition to the control normalized cell area (no drug) (n = 3). Error bars: SD.
Table 1.
IC50 values for 5-FU for the three cell lines at 24h and 48h in 2D versus 3D spheroids.
A range of IC50 values (e.g., 1–2 μM) indicates that the precise IC50 was in between two concentrations tested.
Fig 8.
(A-C) Time series of the Cell Index obtained by RTCA impedance assay for the three CRC cell lines after 5-FU treatment administrated at initial time ([5FU] ranging from 0 to 100 μM, see colour code on the right). (D-F) Time series of the normalized cell area obtained by the videomicroscopy assay for the three CRC cell lines after 5-FU treatment administrated at initial time. Error bars: SD. Results from three distinct experiments in triplicate conditions.